2 years ago

Broken String Biosciences Raises £12.1m for US Expansion

  • Broken String Biosciences, a biotech company based in Cambridge, has closed a £12.1m Series A investment led by Illumina Ventures and Mérieux Equity Partners

  • The funding will support the company's move into the US and new hires in Cambridge.

      • ProblemHealthcare

      "Accurately measuring and assessing off-target gene editing during therapeutic development is crucial for ensuring the safety and efficacy of cell and gene therapies."

      Solution

      "Broken String Biosciences has developed INDUCE-seq, a DNA mapping platform that provides an unbiased, end-to-end solution for measuring and assessing off-target gene editing, giving researchers a comprehensive view of the genome editing process and enabling them to develop safer and more effective therapies."

      Covered on